IPBronch.com | Interventional Pulmonology

🎯 Background & Rationale

Conventional transbronchial lung cryobiopsy for peripheral pulmonary lesions (PPLs) typically requires repeated removal of the bronchoscope to thaw and retrieve specimens, creating a blind period and increasing procedural complexity. While guide sheath-based ultrathin cryobiopsy (1.1-mm probe) allows specimen retrieval without scope removal, it yields smaller samples and limits freezing times due to working channel constraints. This multicenter prospective observational study evaluates a novel technique: direct cryobiopsy specimen retrieval using a 1.1-mm cryoprobe through the 3.0-mm working channel of a therapeutic bronchoscope, aiming to balance larger sample acquisition with immediate, stable in-situ bronchoscopic wedging for hemorrhage control.

👥 Study Design & Population

Study Type: Multicentre Prospective Observational Study (Clinical Trial Registry: UMIN000050604).
Population: 96 analyzed patients (out of 100 enrolled) with localized peripheral pulmonary lesions suspected of lung cancer requiring pathological evaluation across two institutions in Japan.
Intervention: Standard forceps biopsy (FB) followed by EBUS-guided cryobiopsy using a 1.1-mm cryoprobe through a therapeutic bronchoscope with a 3.0-mm working channel, utilizing direct en bloc retrieval of the cryoprobe and guide sheath while the bronchoscope remained wedged in the target bronchus for 3 minutes.

📈 Methodology & Rigor

Sample Size & Statistics: Based on an anticipated acceptable proportion of procedures completed without moderate or severe bleeding of approximately 60%, an expected success rate of 70% (threshold 55%), a one-sided alpha of 0.05, and 90% power, a sample size of 89 was calculated (planned for 100). Statistical analyses utilized Mann–Whitney U and Kruskal–Wallis tests for specimen sizes, and McNemar tests for diagnostic yields.
Endpoints: Primary endpoint was procedural safety assessed by bleeding grade (Nashville Working Group classification). Secondary endpoints included procedure-related complications, pathological diagnostic yield, procedure duration, specimen size, sampling success by freezing time, and biomarker test success rate.

🔬 Key Findings [or Planned Endpoints]

Safety & Bleeding: Bleeding severity after a 3-minute wedge was Grade 0 in 35.4% (34/96), Grade 1 in 41.7% (40/96), Grade 2 in 8.3% (8/96), and Grade 3 in 2.1% (2/96) of patients. No bleeding exceeded Grade 3. Non-bleeding complications included pneumonia (1.0%) and pneumothorax (2.1%).
Diagnostic Yield: Specific diagnostic yields were 77.0% (74/96) for FB and 79.1% (76/96) for cryobiopsy, combining for an overall specific diagnostic yield of 87.5% (84/96). Cryobiopsy provided the sole diagnosis in 10 patients.
Specimen Size & Biomarkers: Cryobiopsy specimens were significantly larger than FB specimens (median 7.06 vs. 2.46 mm², p < 0.001). The success rate for multiplex genetic/NGS testing on cryobiopsy specimens was 95.8% (23/24).

⚖️ Critical Appraisal

Strengths: Prospective multicenter design, clear operational definitions (Nashville bleeding grades), and objective morphometric measurement of specimen size. It addresses a major operational bottleneck in interventional pulmonology by streamlining hemostasis and specimen retrieval.
Limitations: Conducted at only two centers in Japan, introducing potential institutional/operator bias and limiting generalizability. The non-comparative design and the mandatory sequencing of FB before cryobiopsy limit definitive conclusions regarding independent diagnostic superiority or sequence-dependent bias.

💡 The Clinical Bottom Line

Direct retrieval of 1.1-mm cryobiopsy specimens through the 3.0-mm working channel of a therapeutic bronchoscope is a safe, feasible technique that avoids repeated scope removal, maintains a stable wedged position for hemostasis, and yields significantly larger tissue samples with high diagnostic and molecular biomarker success rates. Interventional pulmonologists can consider this approach to optimize both tissue acquisition and bleeding management during advanced bronchoscopy for PPLs.

Background and Objective Cryobiopsy using a 1.1-mm cryoprobe through a therapeutic bronchoscope with a 3.0-mm working channel permits en bloc retrieval of the cryoprobe and guide sheath while the bronchoscope remains wedged in the target bronchus, potentially facilitating immediate haemostatic control. This study investigated the safety and efficacy of this technique. Methods This prospective observational study enrolled patients with peripheral pulmonary lesions suspected of lung cancer who underwent forceps biopsy (FB), followed by cryobiopsy using a 1.1-mm cryoprobe through a therapeutic bronchoscope with a 3.0-mm working channel. The primary endpoint was procedural safety, as assessed by bleeding grade. The secondary endpoints included procedure-related complications, diagnostic yield, specimen size, procedural success rate, and biomarker analysis success rate. Results Of 100 enrolled patients, 96 were included in the analysis, and 84 underwent cryobiopsy. Bleeding severity was Grade 0 in 35.4% (34 of 96), Grade 1 in 41.7% (40 of 96), Grade 2 in 8.3% (8 of 96), and Grade 3 in 2.1% (2 of 96) of patients. Diagnostic yields were 77.0% (74 of 96) for FB and 79.1% (76 of 96) for cryobiopsy, with an overall yield of 87.5% (84 of 96). Cryobiopsy provided the sole diagnosis in 10 patients and yielded significantly larger specimens than FB (7.06 vs. 2.46 mm2; p < 0.001). The success rate of multiplex genetic testing was 95.8% for cryobiopsy (23 of 24). Conclusion Direct retrieval of cryobiopsy specimens through the working channel of a therapeutic bronchoscope is safe and feasible, yielding larger specimens with complementary diagnostic value.